Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.
Source: MarketWatch
Saturday, 18. January 2025
Share:
17. January 2025 14:23
Tripling Wegovy dosage leads to more weight loss, Novo Nordisk trial shows
